429 related articles for article (PubMed ID: 26363973)
21. Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury.
Pan CW; Zhou GY; Chen WL; Zhuge L; Jin LX; Zheng Y; Lin W; Pan ZZ
Int Immunopharmacol; 2015 May; 26(1):80-5. PubMed ID: 25797347
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
Li J; Zhang X; Huang H
Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats.
Wen T; Wu ZM; Liu Y; Tan YF; Ren F; Wu H
Toxicology; 2007 Jul; 237(1-3):184-193. PubMed ID: 17587481
[TBL] [Abstract][Full Text] [Related]
24. Sinapic acid ameliorates D-galactosamine/lipopolysaccharide-induced fulminant hepatitis in rats: Role of nuclear factor erythroid-related factor 2/heme oxygenase-1 pathways.
Ansari MA; Raish M; Bin Jardan YA; Ahmad A; Shahid M; Ahmad SF; Haq N; Khan MR; Bakheet SA
World J Gastroenterol; 2021 Feb; 27(7):592-608. PubMed ID: 33642831
[TBL] [Abstract][Full Text] [Related]
25. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
26. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
27. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice.
Liu A; Shen Y; Du Y; Chen J; Pei F; Fu W; Qiao J
Microb Pathog; 2018 Dec; 125():418-422. PubMed ID: 30290266
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of p-methoxyl-diphenyl diselenide in lethal acute liver failure induced by lipopolysaccharide and D-galactosamine in mice.
Wilhelm EA; Jesse CR; Nogueira CW
Fundam Clin Pharmacol; 2009 Dec; 23(6):727-34. PubMed ID: 19682082
[TBL] [Abstract][Full Text] [Related]
29. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
[TBL] [Abstract][Full Text] [Related]
30. Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Misawa H; Ohashi W; Tomita K; Hattori K; Shimada Y; Hattori Y
Toxicol Appl Pharmacol; 2017 Nov; 334():55-65. PubMed ID: 28887131
[TBL] [Abstract][Full Text] [Related]
31. Panaxynol from
Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
[TBL] [Abstract][Full Text] [Related]
32. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
33. [CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].
Wu Y; Liang L; Shi G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1009-12. PubMed ID: 25270198
[TBL] [Abstract][Full Text] [Related]
34. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
[TBL] [Abstract][Full Text] [Related]
35. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
[TBL] [Abstract][Full Text] [Related]
36. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
[TBL] [Abstract][Full Text] [Related]
38. The polysaccharides from the
Meng M; Zhang R; Han R; Kong Y; Wang R; Hou L
Food Funct; 2021 Mar; 12(5):1973-1982. PubMed ID: 33586729
[TBL] [Abstract][Full Text] [Related]
39. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
40. BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.
Yan D; Liu HL; Yu ZJ; Huang YH; Gao D; Hao H; Liao SS; Xu FY; Zhou XY
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
